The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level

IF 6 2区医学 Q1 ECONOMICS Value in Health Pub Date : 2025-06-01 DOI:10.1016/j.jval.2025.03.002

H. Amarens Geuzinge PhD , Mohamed El Alili PhD , Joost J. Enzing PhD , Leonie M. Huis in ’t Veld MSc , Saskia Knies PhD , G. Ardine de Wit PhD , advisory committee

{"title":"The New Dutch Guideline for Economic Evaluations in Healthcare: Taking the Societal Perspective to the Next Level","authors":"H. Amarens Geuzinge PhD , Mohamed El Alili PhD , Joost J. Enzing PhD , Leonie M. Huis in ’t Veld MSc , Saskia Knies PhD , G. Ardine de Wit PhD , advisory committee","doi":"10.1016/j.jval.2025.03.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><div>To promote uniform and high-quality economic evaluations, several national Health Technology Assessment (HTA) bodies have developed guidelines. Because of ongoing (methodological) developments within the field of HTA and economic evaluations, the Dutch health economic guideline needed a revision. This article briefly discusses the process of the latest revision, highlights most important changes, and presents a research agenda with topics for which more research is desired.</div></div><div><h3>Methods</h3><div>An independent committee of 8 Dutch academic HTA experts was installed to advise the National Health Care Institute on this revision. A survey was sent to all relevant stakeholders to obtain input on adjustments needed. The committee discussed the results from the survey and during 4 meetings, formulated its advice accordingly.</div></div><div><h3>Results</h3><div>The most important revisions are a lowered discount rate for costs, additional guidance concerning expert opinion and expert elicitation, the inclusion of health-related quality of life of informal caregivers, performing probabilistic analysis for the main results, indirect medical costs in life years gained, additional guidance on empirical economic evaluations and the inclusion of value of information analyses. Furthermore, the costing manual has been updated as well, including updated reference prices and additional price categories related to educational and judicial costs.</div></div><div><h3>Conclusions</h3><div>The revised Dutch guideline provides up-to-date guidance for conducting economic evaluations in The Netherlands that can inform health policy decisions from a broad societal perspective.</div></div>","PeriodicalId":23508,"journal":{"name":"Value in Health","volume":"28 6","pages":"Pages 930-935"},"PeriodicalIF":6.0000,"publicationDate":"2025-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Value in Health","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1098301525001160","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ECONOMICS","Score":null,"Total":0}

引用次数: 0

Abstract

Objectives

To promote uniform and high-quality economic evaluations, several national Health Technology Assessment (HTA) bodies have developed guidelines. Because of ongoing (methodological) developments within the field of HTA and economic evaluations, the Dutch health economic guideline needed a revision. This article briefly discusses the process of the latest revision, highlights most important changes, and presents a research agenda with topics for which more research is desired.

Methods

An independent committee of 8 Dutch academic HTA experts was installed to advise the National Health Care Institute on this revision. A survey was sent to all relevant stakeholders to obtain input on adjustments needed. The committee discussed the results from the survey and during 4 meetings, formulated its advice accordingly.

Results

The most important revisions are a lowered discount rate for costs, additional guidance concerning expert opinion and expert elicitation, the inclusion of health-related quality of life of informal caregivers, performing probabilistic analysis for the main results, indirect medical costs in life years gained, additional guidance on empirical economic evaluations and the inclusion of value of information analyses. Furthermore, the costing manual has been updated as well, including updated reference prices and additional price categories related to educational and judicial costs.

Conclusions

The revised Dutch guideline provides up-to-date guidance for conducting economic evaluations in The Netherlands that can inform health policy decisions from a broad societal perspective.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

新的荷兰卫生保健经济评估准则：将社会观点提升到一个新的水平。

目标：为了促进统一和高质量的经济评价，几个国家卫生技术评价机构制定了准则。由于卫生评价和经济评价领域的持续（方法上的）发展，荷兰卫生经济指南需要修订。本文简要讨论了最新修订的过程，突出了最重要的变化，并提出了一个研究议程，其中包括需要进行更多研究的主题。方法：成立了一个由8名荷兰HTA专家组成的独立委员会，就该修订向国家卫生保健研究所提供建议。向所有相关的利益攸关方发送了一份调查，以便获得对所需调整的投入。委员会讨论了调查结果，并在四次会议期间提出了相应的意见。结果：最重要的修订是降低了成本贴现率，增加了关于专家意见和专家启发的指导，纳入了非正式照顾者的健康相关生活质量，对主要结果进行了概率分析，获得的生命年间接医疗费用，增加了经验经济评估的指导，并纳入了信息价值分析。此外，成本计算手册也已增订，包括最新的参考价格和与教育和司法费用有关的额外价格类别。结论：修订后的荷兰准则为在荷兰开展经济评估提供了最新的指导，可以从广泛的社会角度为卫生政策决定提供信息。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Value in Health 医学-卫生保健

CiteScore

6.90

自引率

6.70%

发文量

3064

审稿时长

3-8 weeks

期刊介绍： Value in Health contains original research articles for pharmacoeconomics, health economics, and outcomes research (clinical, economic, and patient-reported outcomes/preference-based research), as well as conceptual and health policy articles that provide valuable information for health care decision-makers as well as the research community. As the official journal of ISPOR, Value in Health provides a forum for researchers, as well as health care decision-makers to translate outcomes research into health care decisions.